Luxempart

M&A Activity • Nov 3, 2022

Siège Social: 12 rue Léon Laval L-3372 Leudelange R.C.S. Luxembourg B 27846 www.luxempart.lu

Press release

Unilabs and RIMED join forces in Switzerland to expand their position in the field of integrated medical diagnostics

Luxempart extends partnership with Rimed founder and remains a minority shareholder

Luxembourg, November 3, 2022

Unilabs, a leading diagnostic services provider, and RIMED, a leading Swiss diagnostic radiology company, announced today a unique partnership that will enable patients and referring facilities in Switzerland to benefit even more from integrated medical diagnostics. With the acquisition of a majority stake in RIMED, Unilabs strengthens its presence in German-speaking Switzerland and Ticino, where RIMED is a leader in the radiology segment. The partnership will allow a simplified patient care thanks to the future integration and consistency of IT solutions and the optimisation of the interdisciplinary data exchange quality. The former management of RIMED and Unilabs will continue to be part of the new organisation, thus guaranteeing continuity.

Luxempart partnered up in 2016 with Dr Kim B. Laver, the founder of RIMED, and actively accompanied the management team in the build-up of the group. Expanding from 13 to 18 sites and growing revenues by 63.8% from 2016 to 2021, RIMED has a broad network of first-class radiology experts in German and Italian-speaking Switzerland. The merger of the 18 radiology sites of RIMED in German and Italian-speaking Switzerland and the 5 radiology centres of Unilabs in French-speaking Switzerland creates a new nationwide high-performance network in the private radiological diagnostics field. The bundling of expertise, the collaboration of highly qualified specialists, and the constant exchange with patients, referring physicians, and all service providers in the medical-diagnostic value chain create enormous potential radiology but also for the diagnostic disciplines of pathology, genetics, and biology. Through the comprehensive new diagnostic offer from a single source, doctors and patients alike will benefit from a faster, more targeted, and comprehensive diagnostics.

Radiology services are an essential part of modern medical diagnostics. All imaging procedures, such as MR and CT, are an essential part of diagnostics and finding a treatment. Accurate, reliable diagnostics are crucial to treat cancer and other diseases. They benefit patients, doctors, service providers, and insurers alike.

In the course of this transaction, Luxempart has reduced its stake in RIMED from 27,4% to 5.5% and has generated an IRR significantly exceeding its long-term objectives.

Mr. John Penning, Managing Director of Luxempart, comments: "We would like to thank Dr Kim Laver and the whole RIMED team for the fruitful collaboration since 2016. RIMED has developed into one of the leading radiology group in Switzerland and we are impressed by RIMED's commitment to innovation for radiologists and quality service to patients. We are convinced that the integration of RIMED into the Unilabs family will benefit all stakeholders and we are looking forward to continue the exciting journey of RIMED within the Unilabs group".

Siège Social: 12 rue Léon Laval L-3372 Leudelange R.C.S. Luxembourg B 27846 www.luxempart.lu

Dr. Kim Laver, Founder of Rimed AG, emphasises: "For RIMED, this is a pivotal milestone in the company's strategic trajectory in terms of growth and performance. Our employees have contributed substantially to the company's success over the past six years with their patient-centric philosophy and engagement, providing highquality diagnostic services. The partnership with Unilabs will complement the achievements of both companies and create an enhanced service provider with a large Swiss footprint in the German, French, and Italian-speaking regions. Through synergies and a patient-oriented service approach, we will be able to provide a unique healthcare platform for patients, referring physicians, and hospitals in the future."

Mr. Alessandre Keller, Unilabs Switzerland General Manager complements: "We are very pleased to welcome RIMED to the Unilabs family. Thanks to this merger, we will be able to expand our reach and provide more patients with high-quality diagnostics. RIMED's world-class radiology services will be part of our integrated clinical diagnostic capabilities. Combining radiology, digital pathology, genetics, and clinical analysis services will allow us to provide 360° medical diagnostics to Swiss patients. Finally, integrated diagnostic care has a face: Unilabs and RIMED, two reliable, innovative, and cost-effective healthcare service providers."

About RIMED

RIMED is a leading provider of medical radiology services in Switzerland, with its head office in Zug. Cooperations in the public and private sector have made the company a reliable and strong partner in the Swiss healthcare market for almost 30 years. At RIMED, everything revolves around the wellbeing of the people who entrust the company with medical radiological services, according to the principle human-competent, patient-oriented. As a highly modern and technologically networked radiology group, RIMED offers its referring doctors a sophisticated electronic platform for all image/findings material. It enables efficient data flows for optimal, rapid, and high-quality data exchange.

About Unilabs

Unilabs is one of Europe's leading diagnostics companies, offering a complete range of laboratory, pathology, and imaging services to patients across four continents. A leading digital champion covering the full diagnostic spectrum, Unilabs' +13,000 people save lives every day.

Unilabs invests heavily in technology, equipment, and people – using digital technologies in its state-of-the-art laboratories and imaging institutes to improve the lives of close to 100 million people every year.

Siège Social: 12 rue Léon Laval L-3372 Leudelange R.C.S. Luxembourg B 27846 www.luxempart.lu

About Luxempart

Luxempart is a Luxembourg-based listed investment company with a net worth of EUR 2.1bn backed by Luxembourgish entrepreneurial families. With permanent capital and a professional investment team, Luxempart provides flexible long-term financing solutions to entrepreneurs, families and management and actively supports its portfolio companies in their growth and international expansion.

Luxempart's Direct Investment strategy consists in investing equity tickets ranging from EUR 25m up to EUR 100m in the DACH region, France, BeLux and Northern Italy.

Contact: John Penning +352 437 43 5117 www.luxempart.lu